Semaglutide Superior to Other GLP-1 Analogues as Add-On to Basal Insulin in T2D
Once-weekly semaglutide 1.0 mg was also equally effective at reducing systolic blood pressure compared with liraglutide 1.8 mg.
Researchers suggest complement pathway activation plays a role in diabetic kidney disease progression in people with proteinuria.
Investigators examined the rates and risk factors for type 2 diabetes in individuals with chronic kidney disease.
Higher levels of aldosterone are associated with insulin resistance and incident type 2 diabetes among multiethnic individuals.